The global biosensors market is expected to reach USD 34.51 billion in 2025 from USD 54.37 billion by 2030, growing at a CAGR of 9.5% during this period. Market growth is driven by the rising number of infectious diseases in developing countries, increasing demand for rapid diagnosis and efficient monitoring solutions, and technological advancements such as miniaturization, nanotechnology, microfluidics, and new product innovations. Additionally, the growing demand in urban areas, where diagnostic devices are easily accessible and simple to use, is further boosting market growth. Governments worldwide are launching initiatives to improve diagnostics and drug services, aiming to ensure availability and access to diagnostic testing while reducing patients’ out-of-pocket expenses.
Extensive primary interviews were conducted with key industry experts in the biosensors market to determine and verify the market size for various segments and subsegments gathered through secondary research. The breakdown of primary participants for the report is shown below: The study includes insights from various industry experts, from component suppliers to Tier 1 companies and OEMs. The breakdown of the primary participants is as follows:
Embedded devices to account for the larger market share in 2030
Embedded devices are commonly used in various applications such as point of care, home diagnostics, food and beverages, research labs, environmental monitoring, and biodefense. With the growth of the Internet of Things (IoT) devices, there has been a significant shift in connected healthcare applications. IoT enables real-time alerts, tracking, and monitoring, which allows for hands-on treatments, improved accuracy, timely interventions by doctors, and overall better patient care. Many healthcare facilities are beginning to adopt embedded solutions for medical devices with IoT capabilities to address the shortage of doctors in remote areas. These IoT-enabled medical devices help identify diseases and perform various tests to deliver accurate and reliable treatment to patients in remote locations. Consequently, the increasing use of embedded devices will boost the market growth of biosensors.Non-wearable (POC) biosensors to capture the largest share of the biosensors market throughout the forecast period
The non-wearable biosensors market is a vibrant growth area driven by diverse applications, from handheld tools to lab systems and point-of-care diagnostics, vital in healthcare, environmental monitoring, and food safety. These biosensors, used in hospitals, research, food, and environmental sectors, enable real-time, on-site monitoring, helping address food quality challenges and meet safety standards. Market growth is fueled by increased awareness of environmental surveillance and the need for rapid devices for biodefense, food control, and pathogen detection.China to hold largest share in Asia Pacific of biosensors market in 2030
The factors driving the biosensors market in China include rapid economic growth and an aging population, along with government efforts to improve healthcare services. Many multinational exporters and producers operating in China have adopted strategies such as acquisitions or strategic partnerships that support reliable domestic distribution and service infrastructure. In contrast, many domestic manufacturers, particularly those focused on export markets outside of China, lack strong distribution and service networks within the country. China is the most populous country in the world, and with the one-child policy, the elderly population is expected to increase in the future. As the population ages, there will likely be a significant rise in the incidence of various disorders, including heart diseases.Extensive primary interviews were conducted with key industry experts in the biosensors market to determine and verify the market size for various segments and subsegments gathered through secondary research. The breakdown of primary participants for the report is shown below: The study includes insights from various industry experts, from component suppliers to Tier 1 companies and OEMs. The breakdown of the primary participants is as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 35%, and Tier 3 - 25%
- By Designation: C-level Executives - 45%, Directors - 35%, and Others - 20%
- By Region: North America - 30%, Europe - 22%, Asia Pacific - 40%, and RoW - 8%
The study includes an in-depth competitive analysis of these key players in the biosensors market, with their company profiles, recent developments, and key market strategies.
- Study Coverage: This research report categorizes the biosensors market based on type (sensor patches, embedded devices), product (wearable, non-wearable), technology (electrochemical, optical, piezoelectric, thermal, nanomechanical), component (bioreceptor molecules, biological elements, transducers), application (POC, home diagnostics, research labs, environmental monitoring, food & beverages, biodefense), and region (North America, Europe, Asia Pacific and RoW). The report describes the major drivers, restraints, challenges, and opportunities pertaining to the biosensors market and forecasts the same till 2030. The report also consists of leadership mapping and analysis of all the companies included in the biosensor ecosystem.
Key Benefits of Buying the Report
The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall biosensors market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.The report provides insights on the following pointers:
- Analysis of key drivers (emergence of nanotechnology-based biosensors, technological advancements, increasing use of biosensors to monitor glucose levels in individuals with diabetes, government initiatives to support diagnostics) restraints (reluctance to adopt new treatment practices, high costs of R&D), opportunities (emerging markets in developing countries, food & environmental monitoring applications, growth opportunities in wearables) and challenges (regulatory barriers and long certification & approval cycles) influencing the growth of the biosensors market
- Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the biosensors market
- Market Development: Comprehensive information about lucrative markets - the report analyzes the biosensors market across varied regions
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biosensors market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) in the biosensors market
Table of Contents
1 Introduction
2 Research Methodology
4 Premium Insights
5 Market Overview
6 Biosensors Market, by Component
7 Biosensors Market, by Type
8 Biosensors Market, by Product
9 Biosensors Market, by Technology
10 Biosensors Market, by Application
11 Biosensors Market, by Region
12 Competitive Landscape
13 Company Profiles
14 Appendix
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Medtronic
- Bio-Rad Laboratories, Inc.
- Dupont
- Biosensors International Group, Ltd.
- Cytiva
- Dexcom, Inc.
- Lifescan Ip Holdings, LLC
- Masimo
- Nova Biomedical
- Universal Biosensors
- Acon Laboratories
- Conductive Technologies
- Eastprint Incorporated
- Ist Ag
- Lifesignals
- Neurosky
- Pinnacle Technology
- Sd Biosensor, Inc.
- Vitalconnect
- Xsensio
- Zimmer and Peacock
- Paragraf Limited
- Dynamic Biosensors
- Linexens
- Biolinq Incorporated
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 228 |
Published | July 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value in 2025 | 34.51 Billion |
Forecasted Market Value by 2030 | 54.37 Billion |
Compound Annual Growth Rate | 9.5% |
Regions Covered | Global |
No. of Companies Mentioned | 27 |